CPH 0.00% 0.9¢ creso pharma limited

Canada exponentially huge, cash flow positive & growing. Many...

  1. 4,418 Posts.
    lightbulb Created with Sketch. 634
    Canada exponentially huge, cash flow positive & growing.
    Many are forgetting milestones are being acheived DYOR

    The new POs follow the Company’s record revenue growth in Q1 FY2023 (refer ASX announcement: 19 April 2023) of 46% on the last quarter to A$1,547,252 and the group’s maiden cash flow positive result. The Company is confident that following the strong start to Q2 FY2023 and recent expansion into Alberta, Mernova will continue to achieve sales growth. Additional updates on new purchase orders and product listing updates with province partners will be made as developments materialise. Management commentary: CEO and Managing Director, Mr William Lay said: “Mernova continues to make very pleasing progress across Canada and the approval to enter Alberta highlights the ongoing product demand the Company is witnessing from provincial partners. “The group will shortly be active in eight of Canada’s ten provinces and we look forward to continuing to build strong brand awareness with key retailers and consumers to drive sales. We are confident that further sales will materialise during the quarter, which will lay a strong foundation for Group revenue
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.